Detalhes do Documento

Photosensitivity to piroxicam: absence of cross-reaction with tenoxicam

Autor(es): Gonçalo, Margarida cv logo 1 ; Figueiredo, A cv logo 2 ; Tavares, P cv logo 3 ; Fontes-Ribeiro, CA cv logo 4 ; Teixeira, F cv logo 5 ; Poiares-Baptista, A cv logo 6

Data: 1992

Identificador Persistente: http://hdl.handle.net/10400.4/680

Origem: Repositório do Centro Hospitalar e Universitário de Coimbra

Assunto(s): Dermatite Fotoalérgica; Piroxicam


Descrição
We studied 2 groups of patients. One group of 10 patients had a photosensitive eruption to piroxicam. Another group of 24 patients had positive patch test reactions to thimerosal and thiosalicylic acid and had never taken piroxicam or tenoxicam. Patients were patch tested with thimerosal 0.1% pet., thiosalicylic acid 0.1% pet., salicylic acid 2.0% pet., piroxicam 1 and 5% pet. and tenoxicam 1 and 5% pet. Photopatch tests were also performed with piroxicam and tenoxicam. All 10 patients with photosensitivity to piroxicam had positive patch tests to thimerosal and thiosalicylic acid and 9 of them had positive photopatch tests to piroxicam. 20 out of 24 patients with positive patch tests to thiosalicylic acid also had positive photopatch tests to piroxicam. All the patients tested with salicyclic acid were negative. Out of the 29 patients with positive photopatch tests to piroxicam, none reacted to tenoxicam. In countries with a high incidence of contact sensitivity to thimerosal/thiosalicylic acid, the use of piroxicam should be avoided and replaced by tenoxicam, a drug without reported photosensitivity.
Tipo de Documento Artigo
Idioma Inglês
delicious logo  facebook logo  linkedin logo  twitter logo 
degois logo
mendeley logo

Documentos Relacionados



    Financiadores do RCAAP

Fundação para a Ciência e a Tecnologia Universidade do Minho   Governo Português Ministério da Educação e Ciência Programa Operacional da Sociedade do Conhecimento União Europeia